−52.6
Elicio Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−22.2
FY23:
−32.7
FY24:
−37.1
FY25:
−37.0
Change from FY21 to FY25
millions USD
FY21:
−0.38
FY22:
−0.65
FY23:
−0.03
FY24:
−0.08
FY25:
−0.02
Change from FY21 to FY25
millions USD
FY21:
107
FY22:
21.2
FY23:
38.6
FY24:
42.3
FY25:
36.7
millions USD
FY21:
54.1
FY22:
−1.63
FY23:
5.89
FY24:
5.19
FY25:
−0.23
(positive)
Change from FY21 to FY25
millions USD
FY21:
−53.0
FY22:
−22.8
FY23:
−32.8
FY24:
−37.2
FY25:
−37.0
All amounts in millions USD